Verona Pharma PLC ADR
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $36,655 | $5,624 | $0 | $0 |
Gross Profit | 34,616 | 5,081 | -270 | -262 |
EBITDA | -14,980 | -34,526 | -53,243 | -23,191 |
EBIT | -15,239 | -34,795 | -53,514 | -23,454 |
Net Income | -33,827 | -42,962 | -70,914 | -25,779 |
Net Change In Cash | 36,655 | 5,624 | 0 | 0 |
Free Cash Flow | -29,371 | -62,655 | -16,784 | -13,982 |
Cash | 399,757 | 336,040 | 404,598 | 254,882 |
Basic Shares | 652,310 | 651,944 | 648,217 | 645,701 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $42,279 | $458 | $458 | $40,000 |
Gross Profit | 39,697 | -679 | 112 | 40,000 |
EBITDA | -138,529 | -52,467 | -67,291 | -42,189 |
EBIT | -139,587 | -53,147 | -67,927 | -42,818 |
Net Income | -173,418 | -54,369 | -68,701 | -55,569 |
Net Change In Cash | 42,279 | 458 | 458 | 40,000 |
Free Cash Flow | -122,203 | -50,222 | -59,891 | -33,266 |
Cash | 399,757 | 271,772 | 227,827 | 148,380 |
Basic Shares | 652,310 | 634,142 | 529,071 | 473,188 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.40 |
2024-09-30 | -$0.56 |
2024-06-30 | -$0.88 |
2024-03-31 | -$0.32 |
